Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma

Area of Science:

• Neuro-oncology
• Cell Biology
• Cancer Therapeutics

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
• GBM cells exhibit resistance to apoptosis and autophagy, limiting therapeutic efficacy.
• Conventional treatments show limited response in GBM patients.

Purpose of the Study:

• To review the components of apoptotic and autophagic pathways in glioblastoma.
• To explore mechanisms of resistance to cell death in glioblastoma.
• To discuss therapeutic strategies targeting glioblastoma cell death and survival pathways.

Main Methods:

• Literature review of apoptosis and autophagy pathways in glioblastoma.
• Analysis of glioblastoma cell resistance mechanisms to cell death.
• Discussion of clinical and preclinical drugs targeting glioblastoma.

Main Results:

• Glioblastoma cells possess multifaceted resistance to apoptosis and autophagy.
• Targeting cell death pathways offers potential therapeutic avenues for glioblastoma.
• Several drugs show promise in preclinical and clinical studies for glioblastoma treatment.

Conclusions:

• Understanding glioblastoma cell death mechanisms is crucial for novel therapy development.
• Targeting apoptosis and autophagy presents a promising strategy for overcoming glioblastoma resistance.
• Further research into therapeutic interventions is warranted for improved glioblastoma outcomes.